What does this report say?
Reading File
Running Command
This is a diagnostic lab report from Agilus Diagnostics for Mr. Ashok Bhavadu Patil, a 72-year-old male. Here's a summary of what it contains:
Patient Details
- Patient: Mr. Ashok Bhavadu Patil, 72 years, Male
- Referring Doctor: Dr. Ajinkya Patil
- Hospital: Lifeline Global Hospital, OPD (Panvel), Mumbai
- Sample Received: 25/05/2026 | Reported: 25/05/2026
- Performed by: Agilus Pathlabs Pvt. Ltd., Mumbai
- Consultant Pathologist: Dr. Sonal Priya
Test Results: Tumor Marker (PSA Panel)
| Test | Result | Reference Range | Units |
|---|---|---|---|
| Free PSA | 0.380 | 0 - 0.50 | ng/mL |
| Total PSA (Prostate Specific Antigen) | 0.675 | Normal: 0 - 4.0 | ng/mL |
Method: CMIA (Chemiluminescent Microparticle Immunoassay)
Interpretation
Both values are well within normal range, which is reassuring:
- Total PSA of 0.675 ng/mL is significantly below the normal upper limit of 4.0 ng/mL. There is no elevation that would suggest prostate cancer, prostatitis, or benign prostatic hyperplasia (BPH) based on this test alone.
- Free PSA of 0.380 ng/mL is also within normal limits (< 0.50 ng/mL).
The lab notes that:
- PSA is useful for monitoring prostate cancer and detecting residual disease or early recurrence.
- Elevated PSA can also occur in non-malignant conditions like prostatitis and BPH.
- American Urological Association guidelines recommend PSA screening for prostate cancer detection in men above age 40.
- PSA levels should ideally be obtained before any biopsy, prostatectomy, or prostatic massage, as manipulation can falsely elevate PSA for up to 3 weeks.
Bottom line: Mr. Ashok Patil's PSA levels are completely normal. There is no biochemical evidence of prostate abnormality in this report. However, these results should always be interpreted alongside clinical findings by the treating physician.
This is a shared conversation. Sign in to Orris to start your own chat.